(Q46908282)

26 December 2017

title

The atypical antipsychotics olanzapine and quetiapine, but not haloperidol, reduce ACTH and cortisol secretion in healthy subjects (English)

1 reference

26 December 2017

0 references

1 reference

Stefan Cohrs

1

1 reference

26 December 2017

Cornelia Röher

2

1 reference

26 December 2017

Wolfgang Jordan

3

1 reference

26 December 2017

Andreas Meier

4

1 reference

26 December 2017

Gerald Huether

5

1 reference

26 December 2017

Wolfgang Wuttke

6

1 reference

26 December 2017

Eckart Rüther

7

1 reference

26 December 2017

Andrea Rodenbeck

8

1 reference

26 December 2017

publication date

24 January 2006

1 reference

26 December 2017

published in

Psychopharmacology

1 reference

26 December 2017

volume

185

1 reference

26 December 2017

issue

1

1 reference

26 December 2017

page(s)

11-18

1 reference

26 December 2017

A comparison of the neuro-endocrinological and temperature effects of DU 29894, flesinoxan, sulpiride and haloperidol in normal volunteers

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00213-005-0279-X

Prolactin Responses to Neuroleptics in Normal and Schizophrenic Subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-005-0279-X

The Effect of Neuroleptics on Serum Prolactin in Schizophrenic Patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-005-0279-X

Treatment of depression with antiglucocorticoid drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-005-0279-X

Effects of receptor blockers (methysergide, propranolol, phentolamine, yohimbine and prazosin) on desimipramine-induced pituitary hormone stimulation in humans--III. Hypothalamo-pituitary-adrenocortical axis

21 January 2018

1 reference

12 December 2020

Effects of mirtazapine on growth hormone, prolactin, and cortisol secretion in healthy male subjects

1 reference

12 December 2020

HPA axis and cytokines dysregulation in schizophrenia: potential implications for the antipsychotic treatment

1 reference

12 December 2020

Effect of the serotonin antagonists ritanserin and ketanserin in Cushing's disease

1 reference

12 December 2020

Ritanserin antagonism of m-chlorophenylpiperazine effects in neuroleptic-free schizophrenics patients: support for serotonin-2 receptor modulation of schizophrenia symptoms

1 reference

12 December 2020

The corticosteroid receptor hypothesis of depression

1 reference

12 December 2020

Separate mechanisms for behavioral, cardiovascular, and hormonal responses to dextroamphetamine in man.

1 reference

12 December 2020

Clinical use of quetiapine in disease states other than schizophrenia.

1 reference

12 December 2020

Quetiapine reduces nocturnal urinary cortisol excretion in healthy subjects

1 reference

12 December 2020

Selective neuroendocrine effects of low-dose haloperidol in normal adult men

1 reference

12 December 2020

Management of the negative symptoms of schizophrenia: new treatment options

1 reference

12 December 2020

Dosing the antipsychotic medication olanzapine

1 reference

12 December 2020

Antipsychotic-induced hyperprolactinaemia in women: pathophysiology, severity and consequences. Selective literature review

1 reference

12 December 2020

Clinical studies on the mechanism of action of clozapine: the dopamine-serotonin hypothesis of schizophrenia

1 reference

12 December 2020

Suppression of HPA-axis activity by haloperidol after experimentally induced heat stress

1 reference

12 December 2020

Circulating levels of corticotrophin and cortisol after infusions of L-DOPA, dopamine and noradrenaline, in man

1 reference

12 December 2020

Neuroendocrine responses to single oral doses of remoxipride and sulpiride in healthy female and male volunteers

1 reference

12 December 2020

Elevation of prolactin levels by atypical antipsychotics

1 reference

12 December 2020

Human prolactin responses to neuroleptic drugs correlate with antischizophrenic potency

1 reference

12 December 2020

Does cognitive function improve with quetiapine in comparison to haloperidol?

1 reference

12 December 2020

Switch from neuroleptics to clozapine does not influence pituitary–gonadal axis hormone levels in male schizophrenic patients

1 reference

12 December 2020

Central dopamine receptors mediating pergolide-induced elevation of serum corticosterone in rats. Characterization by the use of antagonists

1 reference

12 December 2020

Cyproheptadine inhibits the corticotropin releasing hormone (CRH)--induced hormone release in normal subjects

1 reference

12 December 2020

Neurochemical variables in schizophrenic patients during switching from neuroleptics to clozapine

1 reference

12 December 2020

Neurocognitive effects of clozapine, olanzapine, risperidone, and haloperidol in patients with chronic schizophrenia or schizoaffective disorder

1 reference

12 December 2020

Effects of acute administration of zetidoline, a new antidopaminergic drug, on plasma prolactin and aldosterone levels in man.

1 reference

12 December 2020

Haloperidol increases plasma beta endorphin-like immunoreactivity and cortisol in normal human males

1 reference

12 December 2020

Seroquel (ICI 204 636), a putative “atypical” antipsychotic, in schizophrenia with positive symptomatology: results of an open clinical trial and changes of neuroendocrinological and EEG parameters

1 reference

12 December 2020

Effect of adrenergic receptor blockade on cortisol and GH response to insulin-induced hypoglycemia in man

1 reference

12 December 2020

Effect of meclastine, a selective H1 receptor antagonist, upon ACTH release

1 reference

12 December 2020

Corticosteroids and cognition

1 reference

12 December 2020

Prolactin levels in schizophrenia and schizoaffective disorder patients treated with clozapine, olanzapine, risperidone, or haloperidol.

1 reference

12 December 2020

Acute antagonism of dopamine D2-like receptors by amisulpride: effects on hormone secretion in healthy volunteers

1 reference

12 December 2020

Double-blind antiglucocorticoid treatment in schizophrenia and schizoaffective disorder: a pilot study

1 reference

12 December 2020

Effects of ritanserin on the behavioral, neuroendocrine, and cardiovascular responses to meta-chlorophenylpiperazine in healthy human subjects

1 reference

12 December 2020

Adrenergic control of the secretion of anterior pituitary hormones

1 reference

12 December 2020

Increase in Urinary Cortisol Excretion and Memory Declines: MacArthur Studies of Successful Aging1

1 reference

12 December 2020

Sexual dysfunction and plasma prolactin levels in neuroleptic-treated schizophrenic outpatients

1 reference

12 December 2020

A positron emission tomography study of quetiapine in schizophrenia: a preliminary finding of an antipsychotic effect with only transiently high dopamine D2 receptor occupancy

1 reference

12 December 2020

Binding of antipsychotic drugs to human brain receptors focus on newer generation compounds

1 reference

12 December 2020

Cognitive functioning, cortisol release, and symptom severity in patients with schizophrenia

1 reference

12 December 2020

Plasma prolactin in schizophrenia subjects treated with Seroquel (ICI 204,636)

1 reference

12 December 2020

Role of 5-HT in the regulation of the brain-pituitary-adrenal axis: effects of 5-HT on adrenocortical cells

1 reference

12 December 2020

Haloperidol and clozapine treatment and their effect on M-chlorophenylpiperazine-mediated responses in schizophrenia: implications for the mechanism of action of clozapine

1 reference

12 December 2020

Effects of psychotropic drugs (desimipramine, chlorimipramine, sulpiride and diazepam) on the human HPA axis

1 reference

12 December 2020

Antipsychotics: impact on prolactin levels

1 reference

12 December 2020

Depression in schizophrenia: are neuroleptics, akinesia, or anhedonia involved?

1 reference

12 December 2020

Effects of the antipsychotic drug sulpiride on reproductive hormones in healthy men: relationship with body weight regulation

1 reference

12 December 2020

ICI 204,636, an atypical antipsychotic: efficacy and safety in a multicenter, placebo-controlled trial in patients with schizophrenia. U.S. SEROQUEL Study Group

1 reference

12 December 2020

Evidence for two differentially regulated populations of peripheral beta-endorphin-releasing cells in humans.

1 reference

12 December 2020

Endocrine effects of pimozide, a specific dopaminergic blocker

1 reference

12 December 2020

A novel augmentation strategy for treating resistant major depression

1 reference

12 December 2020

Association of depression with medical illness: does cortisol play a role?

1 reference

12 December 2020

The effect of clozapine on plasma norepinephrine: relationship to clinical efficacy

1 reference

12 December 2020

Efficacy of olanzapine and olanzapine-fluoxetine combination in the treatment of bipolar I depression

1 reference

12 December 2020

Prolactin elevation with quetiapine

1 reference

12 December 2020

The effect of olanzapine treatment on m-chlorophenylpiperazine-induced hormone release in schizophrenia

1 reference

12 December 2020

Sulpiride-induced hyperprolactinemia and impotence in male psychiatric outpatients

1 reference

12 December 2020

Attenuation of hypothalamic-pituitary-adrenocortical hyperactivity in depressed patients by mirtazapine

1 reference

12 December 2020

Effects of the antipsychotic drug sulpiride on reproductive hormones in healthy premenopausal women: relationship with body weight regulation

1 reference

12 December 2020

Memory impairment in Cushing's disease.

1 reference

12 December 2020

Correlation of plasma neurosteroid levels to the severity of negative symptoms in male patients with schizophrenia

1 reference

12 December 2020

Neuropsychological change in early phase schizophrenia during 12 months of treatment with olanzapine, risperidone, or haloperidol. The Canadian Collaborative Group for research in schizophrenia

1 reference

12 December 2020

Neurotransmitter regulation of anterior pituitary hormones

1 reference

12 December 2020

10.1007/S00213-005-0279-X

Identifiers

DOI

1 reference

26 December 2017

1 reference

26 December 2017